Ignite Creation Date:
2024-05-06 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 2:19 PM
Study NCT ID:
NCT05152212
Status:
COMPLETED
Last Update Posted:
2024-04-22
First Post:
2021-11-09
Brief Title:
Study of LVGN7409 CD40 Agonist Antibody in Locally Advanced Metastatic or RecurrentRefractory Malignancy
Sponsor:
Lyvgen Biopharma Holdings Limited
Organization:
Lyvgen Biopharma Holdings Limited
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-29
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-19
Completion Date Type:
ACTUAL
First Submit Date:
2021-11-09
First Submit QC Date:
December 7 2021
Study First Post Date:
2021-12-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-18
Last Update Post Date:
2024-04-22
Last Update Post Date Type:
ACTUAL